148 related articles for article (PubMed ID: 27042875)
21. Benzo[a]pyrene diol-epoxide DNA adducts and levels of polycyclic aromatic hydrocarbons in autoptic samples from human lungs.
Lodovici M; Akpan V; Giovannini L; Migliani F; Dolara P
Chem Biol Interact; 1998 Nov; 116(3):199-212. PubMed ID: 9920462
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
[TBL] [Abstract][Full Text] [Related]
25. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
[TBL] [Abstract][Full Text] [Related]
26. Association of methylation of the RAR-β gene with cigarette smoking in non-small cell lung cancer with Southern-Central Chinese population.
Li W; Deng J; Wang SS; Ma L; Pei J; Zeng XX; Tang JX
Asian Pac J Cancer Prev; 2014; 15(24):10937-41. PubMed ID: 25605205
[TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
30. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
31. Epigenome-wide DNA methylation signature of benzo[a]pyrene exposure and their mediation roles in benzo[a]pyrene-associated lung cancer development.
Meng H; Li G; Wei W; Bai Y; Feng Y; Fu M; Guan X; Li M; Li H; Wang C; Jie J; Wu X; He M; Zhang X; Wei S; Li Y; Guo H
J Hazard Mater; 2021 Aug; 416():125839. PubMed ID: 33887567
[TBL] [Abstract][Full Text] [Related]
32. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
[TBL] [Abstract][Full Text] [Related]
33. Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung.
van Schooten FJ; Hillebrand MJ; van Leeuwen FE; van Zandwijk N; Jansen HM; den Engelse L; Kriek E
Carcinogenesis; 1992 Jun; 13(6):987-93. PubMed ID: 1600621
[TBL] [Abstract][Full Text] [Related]
34. [Smoking, the level of DNA adducts and chronic obstructive pulmonary diseases].
Xie JG; Xu YJ; Zhang ZX; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):469-73. PubMed ID: 15312561
[TBL] [Abstract][Full Text] [Related]
35. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
37. BPDE-like DNA adduct level in oral tissue may act as a risk biomarker of oral cancer.
Chuang CY; Tung JN; Su MC; Wu BC; Hsin CH; Chen YJ; Yeh KT; Lee H; Cheng YW
Arch Oral Biol; 2013 Jan; 58(1):102-9. PubMed ID: 22809837
[TBL] [Abstract][Full Text] [Related]
38. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
39. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
40. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
Kim YT; Lee SH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
